Premium Information is available for this item - Upgrade for $1 a day
6505-01-345-2056
Niacin Extended-Release Capsules
6505013452056 013452056 44183 NDC00182-4418-10
INC: 42596 Niacin Extended-Release Capsules
May 2023
7
Marketplace 6505-01-345-2056
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-345-2056 5+ Documents (More...)
6505/us 6505-01-345-2056 Niacin Extended-Release Capsules 013452056 6505/us 6505-01-345-2056 Niacin
Niacin Extended-Release Capsules 013452056 -6505/us 6505-01-335 https /us 6505-01-345-2056 https
Niacin Extended-Release Capsules 013452056 us 6505-01 Niacin Extended-Release Capsules 013452056
00-509-7622 Niacin Extended-Release Capsules 005097622 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-345-2056
Niacin Extended-Release Capsules 013452056 -6505/us 6505-01-335 https /us 6505-01-345-2056 https
Extended-Release Capsules 012691902 Niacin Extended-Release Capsules 012691902 States https 6505/us 6505-01-345-2056
Niacin Extended-Release Capsules 013452056 005097622 6505-01-345-2056 Niacin Extended-Release https
Extended-Release Capsules https Contains 1000 Ea00000001000EA NATO Stock Numbers Related to 6505-01-345-2056
Niacin Extended-Release Capsules 013452056 345-0896 6505-01-335-2642 /us 6505-01-345-2056 https
/us 6505-00-509-7622 Niacin Extended-Release Capsules 005097622 Niacin Extended-Release Capsules 013452056
Restrictions 6505-01-345-2056
6505-01-345-2056 is a Niacin Extended-Release Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-345-2056
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-345-2056
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-345-2056
- Part Number
- Manufacturer
- Status
- 44183
- Manufacturer
- 2U436 - Goldline Laboratories (Active)
- Primary Buy
- Primary Buy
- NDC00182-4418-10
- 2U436 - Goldline Laboratories (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-345-2056
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Capsule Type [AKJC]
- Any Acceptable
- Capsule Content Form [CQLS]
- Any Acceptable
- Active Medicament Medicinal Strength [AKJA]
- 0.500 Milligrams Niacin Released Per Hour
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 1000.000
Management Data 6505-01-345-2056
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Sep 1991
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 1000 Ea
- 00000001000EA
- K
Similar Supply Items to 6505-01-345-2056
Freight Information 6505-01-345-2056
6505-01-345-2056 has freight characteristics.. 6505-01-345-2056 has a variance between NMFC and UFC when transported by rail and the description should be consulted.